168 related articles for article (PubMed ID: 36428972)
21. Subcellular Force Imbalance in Actin Bundles Induces Nuclear Repositioning and Durotaxis.
Jun M; Lee YL; Zhou T; Maric M; Burke B; Park S; Low BC; Chiam KH
ACS Appl Mater Interfaces; 2023 Sep; 15(37):43387-43402. PubMed ID: 37674326
[TBL] [Abstract][Full Text] [Related]
22. Translational pathology, genomics and the development of systemic therapies for acral melanoma.
Chen YA; Teer JK; Eroglu Z; Wu JY; Koomen JM; Karreth FA; Messina JL; Smalley KSM
Semin Cancer Biol; 2020 Apr; 61():149-157. PubMed ID: 31689494
[TBL] [Abstract][Full Text] [Related]
23. YAP facilitates melanoma migration through regulation of actin-related protein 2/3 complex subunit 5 (ARPC5).
Lui JW; Moore SPG; Huang L; Ogomori K; Li Y; Lang D
Pigment Cell Melanoma Res; 2022 Jan; 35(1):52-65. PubMed ID: 34468072
[TBL] [Abstract][Full Text] [Related]
24. Is UV an etiological factor of acral melanoma?
Liu L; Zhang W; Gao T; Li C
J Expo Sci Environ Epidemiol; 2016 Nov; 26(6):539-545. PubMed ID: 26464096
[TBL] [Abstract][Full Text] [Related]
25. Synthetic hydrogels with stiffness gradients for durotaxis study and tissue engineering scaffolds.
Whang M; Kim J
Tissue Eng Regen Med; 2016 Apr; 13(2):126-139. PubMed ID: 30603392
[TBL] [Abstract][Full Text] [Related]
26. Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site.
Jung JM; Jung CJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):498-508. PubMed ID: 33871216
[TBL] [Abstract][Full Text] [Related]
27. High expression of TAZ/YAP promotes the progression of malignant melanoma and affects the postoperative survival of patients.
Feng Q; Guo P; Kang S; Zhao F
Pharmazie; 2018 Nov; 73(11):662-665. PubMed ID: 30396386
[No Abstract] [Full Text] [Related]
28. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
29. The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis.
Zhang X; Yang L; Szeto P; Abali GK; Zhang Y; Kulkarni A; Amarasinghe K; Li J; Vergara IA; Molania R; Papenfuss AT; McLean C; Shackleton M; Harvey KF
Oncogene; 2020 Jul; 39(30):5267-5281. PubMed ID: 32561850
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172).
Nathan P; Ascierto PA; Haanen J; Espinosa E; Demidov L; Garbe C; Guida M; Lorigan P; Chiarion-Sileni V; Gogas H; Maio M; Fierro MT; Hoeller C; Terheyden P; Gutzmer R; Guren TK; Bafaloukos D; Rutkowski P; Plummer R; Waterston A; Kaatz M; Mandala M; Marquez-Rodas I; Muñoz-Couselo E; Dummer R; Grigoryeva E; Young TC; Schadendorf D
Eur J Cancer; 2019 Sep; 119():168-178. PubMed ID: 31445199
[TBL] [Abstract][Full Text] [Related]
31. Human leukocyte antigen Class II alleles associated with acral lentiginous melanoma in Mexican Mestizo patients: A case-control study.
Roldan-Marin R; Rangel-Gamboa L; Vega-Memije ME; Hernández-Doño S; Ruiz-Gómez D; Granados J
Indian J Dermatol Venereol Leprol; 2022; 88(5):608-614. PubMed ID: 35138055
[TBL] [Abstract][Full Text] [Related]
32. Delineating the early dissemination mechanisms of acral melanoma by integrating single-cell and spatial transcriptomic analyses.
Wei C; Sun W; Shen K; Zhong J; Liu W; Gao Z; Xu Y; Wang L; Hu T; Ren M; Li Y; Zhu Y; Zheng S; Zhu M; Luo R; Yang Y; Hou Y; Qi F; Zhou Y; Chen Y; Gu J
Nat Commun; 2023 Dec; 14(1):8119. PubMed ID: 38065972
[TBL] [Abstract][Full Text] [Related]
33. Mathematical modelling of cell migration: stiffness dependent jump rates result in durotaxis.
Malik AA; Gerlee P
J Math Biol; 2019 Jun; 78(7):2289-2315. PubMed ID: 30972438
[TBL] [Abstract][Full Text] [Related]
34. Early detection of acral melanoma: A review of clinical, dermoscopic, histopathologic, and molecular characteristics.
Darmawan CC; Jo G; Montenegro SE; Kwak Y; Cheol L; Cho KH; Mun JH
J Am Acad Dermatol; 2019 Sep; 81(3):805-812. PubMed ID: 30731177
[TBL] [Abstract][Full Text] [Related]
35. Collective durotaxis of cohesive cell clusters on a stiffness gradient.
Pi-Jaumà I; Alert R; Casademunt J
Eur Phys J E Soft Matter; 2022 Jan; 45(1):7. PubMed ID: 35072824
[TBL] [Abstract][Full Text] [Related]
36. Method for Investigating Fibroblast Durotaxis.
Kadry H; Lagares D; Al-Hilal TA
Methods Mol Biol; 2021; 2299():227-236. PubMed ID: 34028747
[TBL] [Abstract][Full Text] [Related]
37. General cellular durotaxis induced with cell-scale heterogeneity of matrix-elasticity.
Ebata H; Moriyama K; Kuboki T; Kidoaki S
Biomaterials; 2020 Feb; 230():119647. PubMed ID: 31791844
[TBL] [Abstract][Full Text] [Related]
38. Mechano-growth factor protects against mechanical overload induced damage and promotes migration of growth plate chondrocytes through RhoA/YAP pathway.
Jing X; Ye Y; Bao Y; Zhang J; Huang J; Wang R; Guo J; Guo F
Exp Cell Res; 2018 May; 366(2):81-91. PubMed ID: 29470961
[TBL] [Abstract][Full Text] [Related]
39. Targeting Mechanics-Induced Fibroblast Activation through CD44-RhoA-YAP Pathway Ameliorates Crystalline Silica-Induced Silicosis.
Li S; Li C; Zhang Y; He X; Chen X; Zeng X; Liu F; Chen Y; Chen J
Theranostics; 2019; 9(17):4993-5008. PubMed ID: 31410197
[TBL] [Abstract][Full Text] [Related]
40. SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma.
Loria R; Laquintana V; Scalera S; Fraioli R; Caprara V; Falcone I; Bazzichetto C; Di Martile M; Rosanò L; Del Bufalo D; Bossi G; Sperduti I; Terrenato I; Visca P; Soddu S; Milella M; Ciliberto G; Falcioni R; Ferraresi V; Bon G
J Exp Clin Cancer Res; 2022 Apr; 41(1):148. PubMed ID: 35440004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
